Odyssey Health, Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
Odyssey Health, Inc. (ODYY) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of $278.72 thousand for the 9-month period ending 2026-04-30, per its 10-Q filed 2026-06-12.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2026-06-12
- Odyssey Health, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2025-10-31 was $6.50K, a 87.37% decline year-over-year.
- Odyssey Health, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2024-10-31 was $51.49K, a 68.02% decline year-over-year.
- Odyssey Health, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2023-10-31 was $161.02K.
- Odyssey Health, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2022-10-31 was -$22.04K.
- Odyssey Health, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2025 was $16.70K.
- Odyssey Health, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2024 was -$34.49K.
- Odyssey Health, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was -$35.67K.
- Odyssey Health, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2022 was -$35.67K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month as first filed |
|---|---|---|---|---|---|
| 2026-04-30 | $278.72K 10-Q · filed 2026-06-12 | ||||
| 2026-01-31 | $597.24K 10-Q · filed 2026-03-12 | ||||
| 2025-10-31 | $6.50K 10-Q · filed 2025-12-11 | ||||
| 2025-07-31 | $16.70K 10-K · filed 2025-10-29 | ||||
| 2025-04-30 | $807.00 10-Q · filed 2026-06-12 | ||||
| 2025-01-31 | $4.81K 10-Q · filed 2026-03-12 | ||||
| 2024-10-31 | $51.49K 10-Q · filed 2025-12-11 | ||||
| 2024-07-31 | -$34.49K 10-K · filed 2025-10-29 | ||||
| 2024-04-30 | $29.15K 10-Q · filed 2025-06-13 | ||||
| 2024-01-31 | $129.28K 10-Q · filed 2025-03-14 | ||||
| 2023-10-31 | $161.02K 10-Q · filed 2024-12-16 | ||||
| 2023-07-31 | -$35.67K 10-K · filed 2024-11-13 | ||||
| 2023-04-30 | -$71.30K 10-Q · filed 2024-06-14 | ||||
| 2023-01-31 | -$36.74K 10-Q · filed 2024-03-22 | ||||
| 2022-10-31 | -$22.04K 10-Q · filed 2023-12-15 | ||||
| 2022-07-31 | -$35.67K 10-K · filed 2023-10-30 | -$484.05K 10-K · filed 2022-10-31 | |||
| 2022-04-30 | -$290.28K 10-Q · filed 2023-06-14 | ||||
| 2022-01-31 | -$425.25K 10-Q · filed 2023-03-17 | ||||
| 2021-10-31 | -$85.44K 10-Q · filed 2022-12-14 | ||||
| 2021-07-31 | -$484.05K 10-K · filed 2023-10-30 | $493.63K 10-K · filed 2021-10-29 | |||
| 2021-04-30 | $1.32M 10-Q · filed 2022-06-14 | ||||
| 2021-01-31 | $120.00 10-Q · filed 2022-03-15 | ||||
| 2020-10-31 | $229.80K 10-Q · filed 2021-12-10 | ||||
| 2020-07-31 | -$104.14K 10-K · filed 2021-10-29 | ||||
| 2020-04-30 | -$140.45K 10-Q · filed 2021-06-21 |